Metronidazole Svp Pharma

Metronidazole, the active ingredient in Metronidazole Svp Pharma, is a nitroimidazole antibiotic presented as an intravenous solution for intravenous use. It treats anaerobic bacterial infections, intra‑abdominal infections, pelvic inflammatory disease, bacterial vaginosis, trichomoniasis, and Clostridioides difficile colitis in adult patients. GNH USA supplies Metronidazole Svp Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Metronidazole is a nitroimidazole antibiotic that targets anaerobic bacteria and certain protozoa. - Anaerobic bacterial infections: eradicates anaerobic organisms to resolve infection. - Intra‑abdominal infections: controls mixed aerobic‑anaerobic infections within the abdominal cavity. - Pelvic inflammatory disease: eliminates anaerobic pathogens contributing to PID. - Bacterial vaginosis: restores normal vaginal flora by suppressing anaerobic overgrowth. - Trichomoniasis: kills Trichomonas vaginalis, the protozoan cause of the disease. - Clostridioides difficile colitis: reduces toxin‑producing C. difficile bacteria in the colon.

Metronidazole may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: occasional mild headache. - Diarrhea: loose stools during therapy. - Abdominal pain: cramping or discomfort. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate attention. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reaction (anaphylaxis): rapid onset of hives, swelling, or breathing difficulty. - Stevens‑Johnson syndrome: severe skin rash and mucosal involvement. - Liver toxicity: elevated liver enzymes or hepatitis. - Neutropenia: marked reduction in white blood cells.

Metronidazole should be used with careful clinical oversight. - Assess renal function: adjust therapy in patients with impaired kidney function. - Monitor hepatic function: watch for liver enzyme elevations during prolonged use. - Avoid alcohol: prevent disulfiram‑like reactions. - Use with caution in pregnancy: category B, discuss risks with obstetrician. - Use with caution in patients with CNS disorders: monitor for seizures or neuropathy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metronidazole can interact with several medicines, requiring vigilance.

Major Interactions (Avoid): - Alcohol: may cause severe disulfiram‑like reaction. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: may increase lithium toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: reduces metronidazole plasma levels. - Cimetidine: may raise metronidazole concentrations. - Carbamazepine: may lower metronidazole exposure.